Clinical efficacy of adenomyomectomy using "H" type incision combined with Mirena in the treatment of adenomyosis
- PMID: 30882624
- PMCID: PMC6426508
- DOI: 10.1097/MD.0000000000014579
Clinical efficacy of adenomyomectomy using "H" type incision combined with Mirena in the treatment of adenomyosis
Abstract
To evaluate the clinical efficacy and safety of adenomyomectomy using "H" type incision combined with Mirena (LNG-IUS) in the treatment of adenomyosis.A total of 57 women with adenomyosis who underwent adenomyomectomy using "H" type incision combined with LNG-IUS were selected. Visual analog scale (VAS), menstrual flow, uterine volume, serum CA125 levels and hemoglobin amounts were compared before and after the surgery. Meanwhile, postoperative pregnancy, adverse reactions, and recurrence were observed.VAS score, menstrual flow, uterine volume, and serum CA125 levels in 53 patients were significantly reduced after surgery (P < . 001). Moreover, statistical significances were obtained for VAS score at 13 and 6 months, menstrual flow at 1, 3, 6, 12, and 24 months, uterine volume at 1, 3, 6, 12, 24, and 36 months and CA125 levels at 1 and 3 months (P < .05). Of the 5 patients with fertility requirements, 1 became pregnant after IVF-ET, progressed to preterm, and delivered healthy twins. Among all related adverse reactions, amenorrhea was the most common (n = 20, 37.7%). There were no cases of LNG-IUS removal, ectopia, expulsion, and incarceration, except in 2 patients due to pregnancy, 1 due to uterine bleeding, and 1 due to Mirena perforation from incision of the uterine fundus. All patients showed no relapse.Adenomyomectomy using "H" type incision combined with Mirena constitutes a novel and effective conservative surgical procedure for adenomyosis treatment.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
Figures



Similar articles
-
Laparoscopic adenomyomectomy combined with levonorgestrel-releasing intrauterine system in the treatment of adenomyosis: Feasibility and effectiveness.J Obstet Gynaecol Res. 2021 Feb;47(2):613-620. doi: 10.1111/jog.14571. Epub 2020 Nov 10. J Obstet Gynaecol Res. 2021. PMID: 33174318
-
Treatment of symptomatic adenomyosis with the levonorgestrel-releasing intrauterine system.Int J Gynaecol Obstet. 2019 Sep;146(3):357-363. doi: 10.1002/ijgo.12887. Epub 2019 Jun 27. Int J Gynaecol Obstet. 2019. PMID: 31194884
-
[Levonorgestrel-releasing intrauterine system for treatment of dysmenorrhea associated with adenomyosis].Zhonghua Fu Chan Ke Za Zhi. 2006 Jul;41(7):467-70. Zhonghua Fu Chan Ke Za Zhi. 2006. PMID: 17083813 Clinical Trial. Chinese.
-
Emerging indications for the levonorgestrel-releasing intrauterine system (LNG-IUS).Acta Obstet Gynecol Scand. 2012 Jan;91(1):3-9. doi: 10.1111/j.1600-0412.2011.01303.x. Epub 2011 Nov 9. Acta Obstet Gynecol Scand. 2012. PMID: 22007693 Review.
-
Mirena (Levonorgestrel intrauterine system): a successful novel drug delivery option in contraception.Adv Drug Deliv Rev. 2009 Aug 10;61(10):808-12. doi: 10.1016/j.addr.2009.04.022. Epub 2009 May 13. Adv Drug Deliv Rev. 2009. PMID: 19445984 Review.
Cited by
-
Levonorgestrel-Releasing Intrauterine System Improves Menorrhagia-Related Quality of Life in Patients with Symptomatic Adenomyosis.Reprod Sci. 2023 Mar;30(3):966-973. doi: 10.1007/s43032-022-01077-9. Epub 2022 Sep 7. Reprod Sci. 2023. PMID: 36071343
-
Modern view on the diagnostics and treatment of adenomyosis.Arch Gynecol Obstet. 2023 Jul;308(1):171-181. doi: 10.1007/s00404-023-06982-1. Epub 2023 Apr 15. Arch Gynecol Obstet. 2023. PMID: 37060397 Review.
References
-
- Botsis D, Kassanos D, Antoniou G, et al. Adenomyoma and leiomyoma: differential diagnosis with transvaginal sonography. J Clin Ultrasound 1998;26:21–5. - PubMed
-
- Vercellini P, Vigano P, Somigliana E, et al. Adenomyosis: epidemiological factors. Best Pract Res Clin Obstetr Gynaecol 2006;20:465–77. - PubMed
-
- Nelson JR, Corson SL. Long-term management of adenomyosis with a gonadotropin-releasing hormone agonist: a case report. Fertil Steril 1993;59:441–3. - PubMed
-
- Fedele L, Bianchi S, Raffaelli R, et al. Treatment of adenomyosis-associated menorrhagia with a levonorgestrel-releasing intrauterine device. Fertil Steril 1997;68:426–9. - PubMed
-
- Cucinella G, Granese R, Calagna G, et al. Oral contraceptives in the prevention of endometrioma recurrence: does the different progestins used make a difference? Arch Gynecol Obstet 2013;288:821–7. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous